From Casetext: Smarter Legal Research

Apotex Inc. v. Pfizer Inc.

United States Court of Appeals, Federal Circuit
Apr 11, 2005
125 F. App'x 987 (Fed. Cir. 2005)

Opinion

No. 04-1463.

Decided April 11, 2005.

Before MAYER, Circuit Judge, PLAGER, Senior Circuit Judge, and GAJARSA, Circuit Judge.


Apotex Inc. and Apotex Corp. (collectively "Apotex") appeal the judgment of the district court, which dismissed Apotex's declaratory judgment action for lack of jurisdiction. Torpharm, Inc. v. Pfizer, Inc., No. 03-CV-990, 2004 WL 1465756 (D. Del. June 28, 2004). Because Apotex's appeal is moot, we vacate and remand with instructions todismiss.

Less than one week before oral argument, Pfizer covenanted not to sue Apotex for infringement of U.S. Patent No. 4,743,450. A covenant not to sue, such as that provided by Pfizer, moots an action for declaratory judgment. See Amana Refrigeration, Inc. v. Quadlux, Inc., 172 F.3d 852, 855 (Fed. Cir. 1999) ("[A] covenant not to sue . . . is sufficient to divest a trial court of jurisdiction over a declaratory judgment action."). As a result, the judgment and opinion of the district court are vacated and the case is remanded with instructions to dismiss for lack of jurisdiction. See U.S. Bancorp Mortgage Co. v. Bonner Mall P'ship, 513 U.S. 18, 23 (1994) ("[V]acatur must be granted where mootness results from the unilateral action of the party who prevailed in the lower court."); Najjar v. Ashcroft, 273 F.3d 1330, 1340 (11th Cir. 2001); Mayfield v. Dalton, 109 F.3d 1423, 1427 (9th Cir. 1997).

COSTS

Apotex shall have its costs.


Summaries of

Apotex Inc. v. Pfizer Inc.

United States Court of Appeals, Federal Circuit
Apr 11, 2005
125 F. App'x 987 (Fed. Cir. 2005)
Case details for

Apotex Inc. v. Pfizer Inc.

Case Details

Full title:APOTEX INC. (formerly known as TorPharm, Inc.) and APOTEX CORP.…

Court:United States Court of Appeals, Federal Circuit

Date published: Apr 11, 2005

Citations

125 F. App'x 987 (Fed. Cir. 2005)

Citing Cases

QRG, Ltd. v. Nartron Corp.

b. Communication Between Parties A general statement that one party intends to enforce its patents does not…

Mylan Pharmaceuticals Inc. v. Merck Co., Inc.

The statement that "[Merck] intends to vigorously defend its patents, which it believes are valid, against…